Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Gilead Sciences Inc buy BMO Capital Markets

Start price
€105.60
13.01.26 / 50%
Target price
-
13.01.27
Performance (%)
9.85%
Price
€116.00
26.01.26
Summary
This prediction is currently active. With a performance of 9.85%, the BUY prediction by BMO_Capital_Markets for Gilead Sciences Inc is trending in the right direction. This prediction currently runs until 13.01.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this prediction
Performance without dividends (%)
Name 1w
Gilead Sciences Inc 9.890%
iShares Core DAX® -0.121%
iShares Nasdaq 100 0.081%
iShares Nikkei 225® -1.748%
iShares S&P 500 -0.961%

Comments by BMO_Capital_Markets for this prediction

In the thread Gilead Sciences Inc diskutieren

Gilead Sciences (NASDAQ:GILD) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Ratings data for GILD provided by MarketBeat

Stopped prediction by BMO_Capital_Markets for Gilead Sciences Inc

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€113.00
26.01.26
€126.35
26.01.27
2.65%
26.01.26

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€105.20
20.10.25
€115.78
20.10.26
11.02%
26.01.26

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€100.00
12.02.25
€110.81
12.02.26
19.16%
26.01.26

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€89.58
07.11.24
€94.44
07.11.25
15.85%
08.11.25

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€80.64
17.10.24
€86.86
17.10.25
30.46%
18.10.25

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€73.00
16.05.23
€91.88
16.05.24
-14.51%
17.05.24